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INTRODUCTION
TISSUE ENGINEERING is a multidisciplinary field of bio-medical research that merges the fields of cellular
and molecular biology, cell and tissue culture techniques,
and materials sciences to recreate tissue for treatments
involving reconstruction or replacement. New biocom-
patible materials are developed constantly for use as scaf-
folds in tissue engineering of a wide variety of tissues
and structures such as cartilage, bone, liver, blood ves-
sels, heart valves, and the knee meniscus.1–19 In general,
however, depending on the tissue that is to be engineered,
two main tissue-engineering approaches can be distin-
guished.
In the first and currently the most popular approach,
cells are seeded onto scaffolds and cultured in vitro to
form a construct that subsequently is implanted into a
laboratory animal. Here the construct can further mature
and/or start functioning immediately. Although success-
ful in some cases (i.e., heart valves20), the main disad-
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ABSTRACT
The continuous development of new biomaterials for tissue engineering and the enhancement of tis-
sue ingrowth into existing scaffolds, using growth factors, create the necessity for developing ade-
quate tools to assess tissue ingrowth rates into porous biomaterials. Current histomorphometric
techniques evaluating rates of tissue ingrowth tend either to measure the overall tissue content in
an entire sample or to depend on the user to indicate a front of tissue ingrowth. Neither method is
particularly suitable for the assessment of tissue ingrowth rates, as these methods either lack the
sensitivity required or are problematic when there is a tissue ingrowth gradient rather than an ob-
vious tissue ingrowth front. This study describes a histomorphometric method that requires little
observer input, is sensitive, and renders detailed information for the assessment of tissue ingrowth
rates into porous biomaterials. This is achieved by examining a number of computer-defined con-
centric zones, which are based on the distance of a pixel from the scaffold edge. Each zone is auto-
matically analyzed for tissue content, eliminating the need for user definition of a tissue ingrowth
front and thus reducing errors and observer dependence. Tissue ingrowth rates in two biodegrad-
able polyurethane scaffolds (Estane and polycaprolactone–polyurethane [PCLPU]) specifically de-
signed for tissue engineering of the knee meniscus were assessed. Samples were subcutaneously im-
planted in rats with follow-up until 6 months. Especially at the earlier follow-up points, PCLPU
scaffolds showed significantly higher tissue ingrowth rates than Estane scaffolds, making the PCLPU
scaffold a promising candidate for further studies investigating meniscus tissue engineering.
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vantage of this approach is that cells in the tissue-engi-
neered construct must deal with a relative lack of nutri-
ents in vivo in the early posttransplantation period, as
compared with the ideal circumstances they were accus-
tomed to in vitro. This dearth of resources may result in
cell death and ultimately lead to failure of the entire tis-
sue engineering construct.21–23
In the alternative approach that is gaining popularity,
especially with the advent of so-called smart scaf-
folds,24–26 acellular scaffolds are implanted into a labo-
ratory animal. Rather than relying on in vitro seeding of
cells as in the first approach, this alternative approach re-
lies on in vivo ingrowth of surrounding tissue into the
scaffold with subsequent proliferation and differentiation
into the desired tissue. Especially in large three-dimen-
sional (3D) scaffolds, with a size exceeding the critical
diffusion distance, this approach will be useful when in-
growth of vascularized tissue can be induced.25
The development of new biomaterials for tissue engi-
neering, and the enhancement of tissue ingrowth into ex-
isting materials by means of attaching growth factors
(“smart scaffolds”), create the necessity to develop tools
for assessment of tissue ingrowth rates into porous bio-
materials. With the advent of sophisticated image analy-
sis software and desktop processing power, for most
groups histomorphometry will be the most affordable and
versatile tool for this purpose.
Current histomorphometric techniques to assess rates
of tissue ingrowth into a scaffold tend to depend on ei-
ther a user-defined tissue ingrowth front27 or an overall
measurement of the tissue content in an entire sample.28
Neither method is particularly suited for assessment of
the rate of tissue ingrowth. A clear tissue ingrowth front
is often difficult to define or even absent, making user
intervention necessary, which is not only time consum-
ing but also inevitably introduces errors. Overall mea-
surement of the tissue content in the entire sample is less
time consuming but can be too crude a method to detect
small differences in tissue ingrowth rates, especially in
large samples or when follow-up intervals are short.
This study investigates tissue ingrowth rates into a
newly developed polycaprolactone–polyurethane scaf-
fold (PCLPU) and an existing Estane scaffold currently
being studied by the authors for use in meniscus tissue
engineering.18 On degradation in vivo, Estane scaffolds
are thought to release potentially toxic and carcinogenic
metabolites, such as methylenedianiline29 that may pre-
vent clinical application of such scaffolds in patients. A
histomorphometric analysis was performed on scaffold
samples that had been implanted subcutaneously in rats
with follow-up times of up to 6 months. If the nontoxic
PCLPU scaffold30,31 allows sufficient tissue ingrowth, it
provides a promising alternative to Estane for further an-
imal and clinical studies investigating biodegradable
scaffolds for use in meniscus tissue engineering.
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We aimed to determine whether the extent and rate of
tissue ingrowth in PCLPU scaffolds differ from those in
Estane scaffolds. In addition, we aimed to demonstrate
the application of a histomorphometric method that is
sensitive and fast, and that renders detailed information
for the assessment of tissue ingrowth rates while requir-
ing minimal observer input.
MATERIALS AND METHODS
Polymers
Estane 5701-F1 implants (BF Goodrich Chemical,
Westerlo-Oevel, Belgium) consisted of a 4,4-methyl-
enediphenyldiisocyanate-based hard segment and a soft
segment of adipic acid and butane diol. Estane was dis-
solved in 1,4-dioxane at 80°C (35%, w/w) and water (8%
[w/w] relative to dioxane) was added as a nonsolvent.
The polymer solution was mixed with saccharose crys-
tals (150–350 m) and cooled 18°C. After freezing, the
solvent was removed by freeze-drying and subsequently
the saccharose was dissolved in water to create pores.32
The PCLPU scaffolds consisted of a hard segment of
1,4-butanediisocyanate and butane diol and a soft seg-
ment of poly(-caprolactone) and were synthesized as de-
scribed elsewhere.33 Pores in the PCLPU scaffolds were
created by adding sodium chloride crystals (150–355
m) that were washed out afterward.33 All pores were
interconnected to achieve high permeability of the poly-
mer. Porosity was 78%. The compression modulus of
both implants at 20% strain was 300 kPa. Both PCLPU
and Estane scaffold samples were manually cut into cubes
of 7  7  7 mm.
Surgery
Twenty-four male Wistar rats between 200 and 250 g
underwent surgery while anesthetized with nitrous oxide
(1:1) and isoflurane (0.5%). After shaving and disinfect-
ing the skin, two skin incisions were made in the back
of each rat. A narrow, subcutaneous tunnel was created
toward each upper extremity of the rat by mobilizing the
skin from the underlying fascia. One sample of a scaf-
fold material was placed at the end of a tunnel, roughly
over the scapula. Each rat received two scaffold samples,
one of each material. The dorsal skin incision was closed
with three staple clips.
The Wistar rats were housed under standard GLP con-
ditions, with an adequate supply of food and water. The
institutional animal welfare committee approved all pro-
cedures.
One, 4, 8, and 26 weeks postimplantation, six rats were
killed with a lethal dose of nitrous oxide (1:1) and isoflu-
rane (0.5%), after which scaffold samples were carefully
harvested from the subcutaneous compartment.
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Histology
Scaffold samples were fixed in acetone (20°C) for 
6 h, infiltrated in methylmethacrylate, and polymerized
at 20°C for 2 days. Sections (7 m thick) were cut from
the middle of each sample. This way the center of a sec-
tion corresponds with the center of a 7  7  7 mm scaf-
fold cube. As samples were found to rotate quite easily
in the loose connective tissue of the subcutaneous com-
partment, it was unlikely that the spatial orientation of
the midsections (regarding the x, y, or z axis) was of much
influence on ingrowth. Sections were dried at 37°C,
deacrylated in warm xylol, and stained. In each section,
Sudan black was used to stain the polymer blue and nu-
clear fast red was used to stain the ingrown tissue red;
this includes the cell body and the extracellular matrix
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deposited by these cells. Unfilled pores obviously re-
mained unstained. All samples were stained according to
the same protocol and in a limited number of batches,
ensuring a highly homogeneous staining intensity for all
samples.
Three sections of each sample were microscopically
assessed (magnification, 40) (Axioplan 2 microscope;
Carl Zeiss, Thornwood, NY) to determine the nature of
the ingrown tissue and to determine the presence of a for-
eign body reaction (i.e., presence of macrophages, giant
cells, and polymorphonuclear leukocytes).
Histomorphometry
Sections were digitized at a magnification of 25 and
a resolution of 1600  1200 pixels, using a Camedia C-
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FIG. 1. (a)Original digitized image that is outlined by the observer. (b) The outline is converted to a binary mask. (c) Gray-
scale euclidian distance map based on binary mask. Pixels are lighter the farther away their location is from the edge. (d–f) Seven
threshold ranges are applied to the distance map to create seven binary masks representing the zones (only three are shown here:
zone 1, zone 2, and zone 3). (g) Colors in the original image are adjusted in the hue–saturation–intensity range to create optimal
contrast between tissue (green) and scaffold (red). (h and i) False color coding indicating each zone being measured separately,
using the binary masks shown under (d) and (e).
4040 digital camera (Olympus America, Melville, NY)
mounted on a Zeiss Axioplan 2 microscope. Image cal-
culations and measurements were performed with analy-
SIS imaging software (Soft Imaging System, Münster,
Germany).
A user-defined outline of each specimen was semiin-
teractively created and converted into a black-and-white
mask. A gray-scale euclidian distance map was computed
from the black-and-white mask and thresholds were ap-
plied, using seven gray-level ranges of equal width.
Seven binary images were created in this way, serving as
zone-delimiting masks in further analysis of the original
digital image (Fig. 1a–f). Using this procedure, the user-
defined outline of each specimen was automatically di-
vided into seven consecutive concentric zones of ap-
proximately 500 m. Zone 1 represents the outer 500 m
of a specimen, zone 2 the layer between 500 and 1000
m, and so on. Zone 7 consists of the center of the spec-
imen (Fig. 2).
To optimize color contrasts between ingrown tissue and
polymer scaffold in the red–green–blue spectrum, adjust-
ments were made in the hue–saturation–intensity spec-
trum of the original digital images (Fig. 1g). These ad-
justments were the same for all samples and were
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automatically applied to all images by the image analysis
routine; no user input was required. In this way, polymer
scaffold material that was stained blue by the Sudan black
became bright red in the adjusted image, whereas ingrown
tissue that was stained pink by the nuclear fast red be-
came bright green in the adjusted image. Red–green–blue
thresholds were then automatically applied to distinguish
between scaffold material, tissue, and unfilled pores by
color. A color-coded preview was then presented to the
user to check the quality of the threshold settings and to
allow for any minor adjustments. As the staining was ho-
mogeneous, similar threshold settings were used for all
samples. Pixels representing tissue were counted and ex-
pressed as a percentage of the total number of pixels in
each zone, resulting in an area percentage for each zone
in each specimen (Fig. 1h and i, and Fig. 3).
Statistical analysis
Analysis of variance (ANOVA) were performed, one
for each zone, testing for the main effects of postim-
plantation time and scaffold material on tissue ingrowth
into the samples. An interaction factor between postim-
plantation time and scaffold material was added to the
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FIG. 2. Definition of seven concentric zones. All zones are of equal width.
ANOVA model to enable testing for significant differ-
ences in tissue ingrowth rates. Post hoc Tukey tests were
used to test for statistical significant differences in tissue
ingrowth between the two polymers for corresponding
zones at corresponding postimplantation time points
(  0.05). In addition, differences between zones were
examined per scaffold material, using post hoc Tukey tests.
Between- and within-observer variability
To assess the between-observer and within-observer
variation of the method employed, 16 randomly selected
samples were measured by 2 independent observers.
Within-observer variation was assessed by remeasuring
samples for a second time by one of the observers
(N.N.R.). Absolute differences were calculated. To as-
sess whether the between-observer and within-observer
variations were different for different zones, the correla-
tion between the absolute difference and zone was de-
termined.
In addition, to demonstrate that manual outlining of the
samples hardly influenced measurement variability, sam-
ples were remeasured twice, using outlines of both ob-
servers but color threshold settings of only one observer.
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RESULTS
Histology
Tissue growing into the scaffolds consisted mostly of
fibrous tissue. Initially, at 1 week postimplantation, fields
of fibrin matrix filled the pores of both Estane and
PCLPU scaffolds. This matrix was first populated by
scarce polymorphonuclear lymphocytes, followed by fi-
broblasts that increased in number with longer postim-
plantation times. At 4 weeks postimplantation the extra-
cellular matrix had started to organize and showed more
orientation. At 26 weeks postimplantation the remodel-
ing of the matrix had progressed still further and all pores
were completely filled with fibrous tissue.
Few blood vessels were seen 1 week postimplantation
in contrast to 4 weeks postimplantation, at which time
vascularization of mostly the periphery of the scaffolds
had occurred. Ingrowth of tissue and vessels progressed
with later postimplantation times. Along with the vascu-
larization, more polymorphonuclear lymphocytes could
be found in both scaffold types. Also, a steady increase
in the number of foreign body giant cells was observed
over time on the surface of both scaffold types. In par-
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FIG. 3. In each zone (zone 2 in this case) the area percentage of ingrown tissue is determined. Tissue, scaffold, and empty
pores are automatically color-coded during processing. Color-coding scheme: scaffold, white, empty pore, black; tissue, gray.
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FIG. 4. Area percentage of tissue ingrowth
per zone at 1 week (A), 4 weeks (B), 8 weeks
(C), and 26 weeks (D) postimplantation. Er-
ror bars represent standard errors of the mean.
An asterisk indicates a significant difference
between PCLPU and Estane scaffolds.
ticular, Estane scaffolds 24 weeks postimplantation
showed clusters of macrophages with a brown content.
This was not observed in PCLPU scaffolds. No mor-
phological changes indicating scaffold degradation were
found in either scaffold.
Histomorphometry
Especially at earlier postimplantation times, pores lo-
cated deep within both scaffold types remained empty,
whereas superficial pores already contained some tissue
(Fig. 3). Correspondingly, this can be observed most
clearly in Fig. 4A, where the lines representing 1 week
postoperation show a clear step-off between the superfi-
cial zone 1 and deeper zones. For both scaffold materi-
als, ingrowth into the first zone was significantly differ-
ent from ingrowth into the second and deeper zones.
In addition, progression of ingrown tissue from the sur-
face of the scaffold toward the center was observed over
time. At increasing postimplantation time points more tis-
sue ingrowth was seen and in deeper zones (Figure
4A–D). At 4 weeks postimplantation (Fig. 4B) both lines
show a decline, indicating the presence of a tissue in-
growth gradient. This can also be observed in Figs. 5 and
6. At 8 weeks postimplantation (Fig. 4C) the same fea-
ture can be observed, although to a lesser extent; the de-
cline is less evident. At 26 weeks, deep and superficial
zones show similar area percentages of tissue ingrowth
(differences between zones are not statistically signifi-
cant), resulting in relatively horizontal lines (Fig. 4D).
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Not only does Fig. 4 show that tissue ingrowth pro-
gresses with increasing postimplantation time, but it also
shows that at later postimplantation times tissue ingrowth
continues in zones that were among the first to be in-
vaded by tissue; the area percentage of tissue ingrowth
per zone tends to be higher at later postimplantation pe-
riods, even in the outer zones. This further illustrates the
fact that indeed there is a tissue ingrowth gradient rather
than a tissue ingrowth front.
Statistical analysis
ANOVA testing for the main effects of postimplanta-
tion time (1, 4, 8, and 26 weeks) and scaffold material
on tissue ingrowth showed that there was a significant
difference in ingrowth between the polymers for all zones
(Table 2). When postimplantation time points were con-
sidered separately, post hoc testing showed significant
differences between PCLPU scaffolds and Estane scaf-
folds at 4 weeks post-implantation (Fig. 4B). In all zones,
the polycaprolactone–polyurethane scaffolds showed sig-
nificantly more tissue ingrowth than Estane. No signifi-
cant differences were found at 1, 8, and 26 weeks postim-
plantation.
In the ANOVA, the interaction factor between postim-
plantation time and scaffold material was statistically sig-
nificant for zones 1 through 3 only, indicating signifi-
cantly different ingrowth rates between PCLPU and
Estane in zones 1 through 3, considering postimplanta-
tion times of 1, 4, 8, and 26 weeks (Table 1).
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FIG. 5. Detailed view of a tissue ingrowth gradient, showing the progressive location of tissue within pores. In the upper right-
hand corner, pores hardly contain any tissue, not even along the pore edges. In the lower left-hand corner, pores contain much
more tissue, although the pores are not completely filled yet. Tissue is situated both along the edge of pores but also in the mid-
dle of pores. In the upper left-hand corner, center, and lower right-hand corner tissue is situated mostly along the edge of pores
and hardly in the middle of pores.
Because ingrowth at 26 weeks was complete for both
polymers, 26-week data were noninformative to deter-
mine ingrowth rates. The ANOVA that excluded 26-
week data showed that ingrowth rates of PCLPU and
Estane were significantly different for zones 1 through
6 (Table 2).
Between-observer and within-observer differences are
presented in Table 3. There was no statistically signifi-
cant correlation between absolute difference and zone.
Drawing the outlines a second time by the same observer
caused a mean absolute difference of 0.26% (SEM,
0.058%; 5th percentile, 0.0029%; 95th percentile differ-
ence, 1.1%).
DISCUSSION
This study employs a simple method to assess tissue
ingrowth into a porous biomaterial, resulting in detailed
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quantitative information that can be interpreted easily.
The process is highly automated, reducing the possibil-
ity for human error, interobserver differences, and time
spent on data acquisition. Limitations to this method are
similar to those of any other histomorphometric analysis,
as tissue and biomaterial need to be distinguishable by
color. To the authors’ knowledge, no reports exist in cur-
rent literature employing the same method for assessment
of tissue ingrowth. Although numerous other histomor-
phometric studies measure ingrowth distance unidirec-
tionally and measure ingrowth area,34 we account for
multidirectionality of ingrowth by using ingrowth zones,
which has not been done previously in large scaffolds.
Theoretically, small differences in ingrowth rate will be
detected more reliably using ingrowth zones as compared
with histomorphometric methods that measure the over-
all ingrowth area in an entire sample.
Other histomorphometric methods27 often attempt to
define a tissue ingrowth front, assuming that tissue in-
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TABLE 1. p VALUES IN ANOVA OF DIFFERENCES IN INGROWTH BETWEEN PCLPU 
AND ESTANE ACROSS ALL POST IMPLANTATION TIME POINTS
p Values of difference in tissue ingrowth rates
p Values of difference in tissue ingrowth between PCLPU and Estane
Zone between PCLPU and Estane (interaction between time and material)
1 0.002 0.009
2 0.0005 0.004
3 0.0005 0.017
4 0.0005 0.063a
5 0.0005 0.099a
6 0.0005 0.083a
7 0.0005 0.436a
Abbreviations: ANOVA, analysis of variance; PCLPU, polycaprolactone–polyurethane.
aNot significant.
FIG. 6. Detailed view of a color-coded image illustrating the presence of a tissue ingrowth gradient rather than a clearly de-
fined tissue ingrowth front. Pores (black) in the polymer (white) are usually partially filled with tissue (gray). On the left-hand
side (superficial) pores contain more tissue than on the right-hand side (deep). A clear cutoff cannot be defined.
growth is a dichotomous variable; either a pore is filled
with tissue or it is not. Most of the time, this is not the
case as the filling of a series of neighboring pores coin-
cides, although be it with a slight delay, rather than fill-
ing up consecutively (Figs. 4 and 5). A tissue ingrowth
front may therefore be difficult to define when there ac-
tually is a tissue ingrowth gradient. User intervention is
usually required in these cases. The histomorphometric
method proposed in this study will simply show a gradi-
ent when there is one, without taking any extra time or
effort.
In this study, a user-defined outline was created semi-
interactively by defining the corners of a polygon on the
digitized midsections of the scaffold samples. An auto-
mated edge detection routine optimized for these sam-
ples could have been devised for this task. Alhough per-
haps more time efficient, it is unlikely that such a routine
would have decreased observer variability, as the outline
procedure contributed only approximately 1% to the vari-
ability. Other studies using different samples may bene-
fit from such a edge detection routine, however. Fur-
thermore, we showed that measurement variation was
independent of zone. This emphasizes that the measure-
ment variation will not have caused an underestimation
or overestimation of tissue ingrowth rate. If the mea-
surement variation were dependent on zone, this could
RAMRATTAN ET AL.
have led to wrong conclusions regarding the ingrowth
pattern. Thus, subdivision in zones does not entail any
extra risks of making false inferences on ingrowth rates.
Even though in this study much effort was made to
preserve observer independence, some observer depen-
dence inevitably remains. Optimization of color thresh-
olds used by the image analysis routine to distinguish be-
tween tissue, scaffold, and unfilled pores was done
interactively within constraints. As indicated by our re-
sults of between- and within-observer variability, vari-
ability stemmed predominantly from the optimization of
these settings. This difficulty is inherent to all histomor-
phometric analyses, however, and the authors do not pre-
sume this study to be exempt from those limitations. Nev-
ertheless, in comparison with the frequently used method
that depends on the experience of the user in discerning
where exactly a tissue ingrowth front is located, the pro-
posed method in this study effectively eliminates that
substantial source of both inter- and intraobserver vari-
ability. Especially in samples where there is a tissue in-
growth gradient, as is often the case, the proposed method
could prove to be superior.
PCLPU scaffolds showed ingrowth rates higher than
those in Estane scaffolds. This is best reflected in the 4-
week postimplantation results, where a marked difference
in both amount and depth of tissue infiltration was ob-
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TABLE 2. p VALUES IN ANOVA OF DIFFERENCES IN INGROWTH BETWEEN PCLPU AND ESTANE
ACROSS ALL POST IMPLANTATION TIME POINTS, EXCLUDING 26 WEEKS POSTIMPLANTATION
p Values of difference in tissue ingrowth rates
p Values of difference in tissue ingrowth between PCLPU and Estane
Zone between PCLPU and Estane (interaction between time and material)
1 0.001 0.005
2 0.001 0.001
3 0.0005 0.003
4 0.001 0.017
5 0.001 0.046
6 0.012 0.028
7 0.013 0.26a
aNot significant.
TABLE 3. BETWEEN-OBSERVER AND WITHIN-OBSERVER VARIATION EXPRESSED AS
ABSOLUTE DIFFERENCES IN TISSUE INGROWTH AREA PERCENTAGEa
Between-observer difference Within-observer difference
(%) (%)
Mean  SEM 2.6  0.3 2.0  0.2
5th percentile 0.06 0.10
95th percentile 10.80 5.20
aMeasurements are percentages and therefore absolute differences are expressed as 
percentages as well.
served. Later on, at 26 weeks postimplantation, both scaf-
fold materials were fully infiltrated by tissue already and
differences in ingrowth rates obviously could no longer
be assessed. Most likely, however, tissue ingrowth into
PCLPU scaffolds was completed no later than in Estane
scaffolds.
In this study, no morphological changes indicating
degradation of scaffolds were found after 26 weeks
postimplantation. Indeed, it is unlikely that such changes
could have been observed microscopically at this follow-
up time. A long-term in vitro degradation study of
PCLPU scaffolds showed that even though after 9 months
the deterioration of biomechanical properties of the scaf-
folds was significant, no signs of degradation could be
found by scanning electron microscopy.35
Estane scaffolds and PCLPU scaffolds had identical
permeability, in terms of porosity and pore size, and com-
pression modulus. These scaffold properties are essential
for tissue ingrowth and differentiation into fibrocartilage
when scaffolds are used for meniscus tissue engineer-
ing.36,37 However, two scaffolds manufactured from dif-
ferent materials but with identical porosity, pore size, and
compression modulus do not necessarily demonstrate
equal tissue ingrowth rates as chemical and physical
properties can signifincatly influence biocompatibility. It
therefore remains necessary to test new scaffolds for their
capacity to allow tissue ingrowth and proliferation as re-
sults from other scaffolds cannot be extrapolated auto-
matically. For instance, Estane and PCLPU scaffolds may
have had quite different levels of phase separation be-
tween hard and soft segments. This phenomenon results
in disproportionate amounts of either hard or soft seg-
ment being exposed at the surface of the polymer, shield-
ing the other segment from the scaffold–tissue inter-
face.38 Hard and soft segments differ in hydrophilicity.
It is well known that the level of hydrophilicity of a poly-
mer surface plays an important role in cell adhesion and
proliferation39 and thus quite likely will affect tissue in-
growth. However, differences herein can be mitigated in
vivo when protein-rich extracellular fluids (e.g., blood)
settle down onto the scaffold surface and mediate be-
tween the cells and polymer.
To what extent can the results of our subcutaneous im-
plantation model be extrapolated to meniscus tissue en-
gineering, since the characteristics of the surrounding tis-
sue in this study differ from the characteristics of
meniscus tissue? We believe that subcutaneous implan-
tation of scaffolds can be used to screen polymers as pos-
sible candidates for meniscus implantation studies. A
polymer that presents poor ingrowth at a subcutaneous
implantation site is unlikely to show better ingrowth in a
less favorable environment such as the knee. Indeed, data
on tissue ingrowth in Estane scaffolds that were im-
planted in dog knees showed that tissue ingrowth in this
environment is good.40 Fibrovascular tissue ingrowth into
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3.5-mm-wide Estane meniscus prostheses was complete
3 months postimplantation.40 Because tissue ingrowth for
subcutaneous implanted Estane scaffolds in the present
study was also good, and for PCLPU even better than for
Estane, the nontoxic PCLPU scaffold30,31 is a serious
candidate for an animal study investigating meniscus im-
plantation. However, the ultimate goal is to achieve dif-
ferentiation of ingrown tissue toward fibrocartilage. In
fact, such was observed in the same study. Six months
postimplantation in dogs, fibrocartilage-like tissue was
found in the Estane meniscus prostheses.40 Unfortu-
nately, as previously mentioned, Estane is thought to have
toxic degradation products in the long term.29 Whether
tissue in a PCLPU meniscus prosthesis will show simi-
lar differentiation into fibrocartilage-like tissue remains
to be seen.
In conclusion, this study demonstrates a novel, sensi-
tive, histomorphometric method to assess tissue ingrowth
into porous polymer scaffolds. This method may prove
to be particularly useful when rates of tissue ingrowth are
being investigated in the field of biomaterial development
or modulation of tissue ingrowth by growth factors.
ACKNOWLEDGMENTS
The authors gratefully acknowledge Natasja Lieuwes
and Leon Driessen for excellent technical assistance.
Funding for this research was provided by the Nether-
lands Technology Foundation (NWO/STW 349-4771).
REFERENCES
1. Vacanti, C.A., Langer, R., Schloo, B., and Vacanti, J.P.
Synthetic polymers seeded with chondrocytes provide a
template for new cartilage formation. Plast. Reconstr. Surg.
88, 753, 1991.
2. Grad, S., Kupcsik, L., Gorna, K., Gogolewski, S., and Alini,
M. The use of biodegradable polyurethane scaffolds for car-
tilage tissue engineering: Potential and limitations. Bioma-
terials 24, 5163, 2003.
3. Buma, P., Pieper, J.S., van Tienen, T., van Susante, J.L.,
van der Kraan, P.M., Veerkamp, J.H., van den Berg, W.B.,
Veth, R.P., and van Kuppevelt, T.H. Cross-linked type I
and type II collagenous matrices for the repair of full-thick-
ness articular cartilage defects: A study in rabbits. Bioma-
terials 24, 3255, 2003.
4. Hutmacher, D.W., Ng, K.W., Kaps, C., Sittinger, M., and
Klaring, S. Elastic cartilage engineering using novel scaf-
fold architectures in combination with a biomimetic cell
carrier. Biomaterials 24, 4445, 2003.
5. Frenkel, S.R., and Di Cesare, P.E. Scaffolds for articular
cartilage repair. Ann. Biomed. Eng. 32, 26, 2004.
6. Harris, C.T., and Cooper, L.F. Comparison of bone graft
matrices for human mesenchymal stem cell-directed os-
teogenesis. J. Biomed. Mater. Res. 68A, 747, 2004.
1221
7. Sharma, B., and Elisseeff, J.H. Engineering structurally or-
ganized cartilage and bone tissues. Ann. Biomed. Eng. 32,
148, 2004.
8. Warren, S.M., Nacamuli, R.K., Song, H.M., and Longaker,
M.T. Tissue-engineered bone using mesenchymal stem
cells and a biodegradable scaffold. J. Craniofac. Surg. 15,
34, 2004.
9. Buma, P., Schreurs, W., and Verdonschot, N. Skeletal tis-
sue engineering. From in vitro studies to large animal mod-
els. Biomaterials 25, 1487, 2004.
10. Risbud, M.V., Karamuk, E., Schlosser, V., and Mayer, J.
Hydrogel-coated textile scaffolds as candidate in liver tis-
sue engineering. II. Evaluation of spheroid formation and
viability of hepatocytes. J. Biomater. Sci. Polym. Ed. 14,
719, 2003.
11. Barralet, J.E., Wallace, L.L., and Strain, A.J. Tissue engi-
neering of human biliary epithelial cells on polyglycolic
acid/polycaprolactone scaffolds maintains long-term phe-
notypic stability. Tissue Eng. 9, 1037, 2003.
12. Xu, C.Y., Inai, R., Kotaki, M., and Ramakrishna, S.
Aligned biodegradable nanofibrous structure: A potential
scaffold for blood vessel engineering. Biomaterials 25, 877,
2004.
13. Harding, S.I., Afoke, A., Brown, R.A., MacLeod, A.,
Shamlou, P.A., and Dunnill, P. Engineering and cell at-
tachment properties of human fibronectin–fibrinogen scaf-
folds for use in tissue engineered blood vessels. Bioprocess.
Biosyst. Eng. 25, 53, 2002.
14. He, H., and Matsuda, T. Arterial replacement with com-
pliant hierarchic hybrid vascular graft: Biomechanical
adaptation and failure. Tissue Eng. 8, 213, 2002.
15. Rothenburger, M., Volker, W., Vischer, J.P., Berendes, E.,
Glasmacher, B., Scheld, H.H., and Deiwick, M. Tissue en-
gineering of heart valves: Formation of a three-dimensional
tissue using porcine heart valve cells. ASAIO J. 48, 586,
2002.
16. Kim, W.G., Cho, S.K., Kang, M.C., Lee, T.Y., and Park,
J.K. Tissue-engineered heart valve leaflets: An animal
study. Int. J. Artif. Organs 24, 642, 2001.
17. Buma, P., Ramrattan, N.N., van Tienen, T.G., and Veth,
R.P. Tissue engineering of the meniscus. Biomaterials 25,
1523, 2004.
18. De Groot, J.H., de Vrijer, R., Pennings, A.J., Klompmaker,
J., Veth, R.P., and Jansen, H.W. Use of porous
polyurethanes for meniscal reconstruction and meniscal
prostheses. Biomaterials 17, 163, 1996.
19. Tienen, T.G., Heijkants, R.G., Buma, P., De Groot, J.H.,
Pennings, A.J., and Veth, R.P. A porous polymer scaffold
for meniscal lesion repair. A study in dogs. Biomaterials
24, 2541, 2003.
20. Flanagan, T.C., and Pandit, A. Living artificial heart valve
alternatives: A review. Eur. Cell Mater. 6, 28, 2003.
21. Kim, S.S., Utsunomiya, H., Koski, J.A., Wu, B.M., Cima,
M.J., Sohn, J., Mukai, K., Griffith, L.G., and Vacanti, J.P.
Survival and function of hepatocytes on a novel three-di-
mensional synthetic biodegradable polymer scaffold with
an intrinsic network of channels. Ann. Surg. 228, 8, 1998.
22. Fuchs, J.R., Pomerantseva, I., Ochoa, E.R., Vacanti, J.P.,
and Fauza, D.O. Fetal tissue engineering: In vitro analysis
of muscle constructs. J. Pediatr. Surg. 38, 1348, 2003.
RAMRATTAN ET AL.
23. Horner, H.A., and Urban, J.P. 2001 Volvo Award Winner
in Basic Science Studies: Effect of nutrient supply on the
viability of cells from the nucleus pulposus of the inter-
vertebral disc. Spine 26, 2543, 2001.
24. Lutolf, M.P., Weber, F.E., Schmoekel, H.G., Schense, J.C.,
Kohler, T., Muller, R., and Hubbell, J.A. Repair of bone
defects using synthetic mimetics of collagenous extracel-
lular matrices. Nat. Biotechnol. 21, 513, 2003.
25. Tabata, Y., Miyao, M., Yamamoto, M., and Ikada, Y. Vas-
cularization into a porous sponge by sustained release of
basic fibroblast growth factor. J. Biomater. Sci. Polym. Ed.
10, 957, 1999.
26. Saito, N., and Takaoka, K. New synthetic biodegradable
polymers as BMP carriers for bone tissue engineering. Bio-
materials 24, 2287, 2003.
27. Yamamoto, M., Tabata, Y., Kawasaki, H., and Ikada, Y.
Promotion of fibrovascular tissue ingrowth into porous
sponges by basic fibroblast growth factor. J. Mater. Sci.
Mater. Med. 11, 213, 2000.
28. Wake, M.C., Mikos, A.G., Sarakinos, G., Vacanti, J.P., and
Langer, R. Dynamics of fibrovascular tissue ingrowth in
hydrogel foams. Cell Transplant. 4, 275, 1995.
29. Szycher, M. Biostability of polyurethane elastomers: A crit-
ical review. J. Biomater. Appl. 3, 297, 1988.
30. Pitt, C.G. In: Chasin, M., and Langer, R., eds. Biodegrad-
able Polymers as Drug Delivery Systems. New York: Mar-
cel Dekker, 1990, pp. 71–120.
31. Bogdanov, B., Toncheva, V., Schacht, E., Finelli, L., Sarti,
B., and Scandola, M. Physical properties of poly(ester-ure-
thanes) prepared from different molar mass polycaprolac-
tone-diols. Polymer 40, 3171, 1999.
32. Degroot, J.H., Nijenhuis, A.J., Bruin, P., Pennings, A.J.,
Veth, R.P.H., Klompmaker, J., and Jansen, H.W.B. Use of
porous biodegradable polymer implants in meniscus re-
construction. 1. Preparation of porous biodegradable
polyurethanes for the reconstruction of meniscus lesions.
Colloid Polym. Sci. 268, 1073, 1990.
33. Heijkants, R.G.J.C., van Calck, R.V., De Groot, J.H., Pen-
nings, A.J., Schouten, A.J., van Tienen, T.G., Ramrattan,
N., Buma, P., and Veth, R.P.H. Design, synthesis and prop-
erties of a degradable polyurethane scaffold for meniscus
regeneration. J. Mater. Sci. Mater. Med. 15, 423, 2004.
34. Huffer, W.E., Ruegg, P., Zhu, J.M., and Lepoff, R.B. Semi-
automated methods for cancellous bone histomorphometry
using a general-purpose video image analysis system. J.
Microsc. 173, 53, 1994.
35. Heijkants, R.G.J.C. Polyurethane scaffolds as meniscus re-
construction materials [Ph.D. thesis]. Department of Poly-
mer Chemistry, University of Groningen, Groningen, The
Netherlands, 2004.
36. Klompmaker, J., Jansen, H.W.B., Veth, R.P.H., Nielsen,
H.K.L., de Groot, J.H., and Pennings, A.J. Porous implants
for knee joint meniscus reconstruction: A preliminary study
on the role of pore sizes in ingrowth and differentiation of
fibrocartilage. Clin. Mater. 14, 1, 1993.
37. van Tienen, T.G., Heijkants, R.G.J.C., Buma, P., de Groot,
J.H., Pennings, A.J., and Veth, R.P.H. Tissue ingrowth and
degradation of two biodegradable porous polymers with
different porosities and poresizes. Biomaterials 23, 1731,
2002.
1222
38. Lambda N.M.K., Woodhouse, K.A., and Cooper, S.L., eds.
Surface characterization of polyurethanes. In: Polyurethanes
in Biomedical Applications. Boca Raton, FL: CRC Press,
1998, p. 91.
39. Lee, J. H., and Lee, H.B. A wettability gradient as a tool
to study protein adsorption and cell adhesion on polymer
surfaces. J. Biomater. Sci. Polym. Ed. 4, 467, 1993.
40. van Tienen, T.G. in vivo tissue engineering of the knee joint
meniscus [Ph.D. thesis]. Department of Orthopedics. Uni-
ASSESSING TISSUE INGROWTH RATES IN POROUS SCAFFOLDS
versty Medical Center St. Radboud, Nijmegen, The Nether-
lands, 2004.
Address reprint requests to:
Navin N. Ramrattan, MD
Spank 72
4824 BG Breda, The Netherlands
E-mail: n_ramrattan@yahoo.com
1223
This article has been cited by:
1. Gerjon Hannink, Eric L.W. de Mulder, Tony G. van Tienen, Pieter Buma. 2012. Effect of load on the repair of osteochondral
defects using a porous polymer scaffold. Journal of Biomedical Materials Research Part B: Applied Biomaterials 100B:8,
2082-2089. [CrossRef]
2. Han Su Kim, Sung Min Chung, Soo Yeon Jung, Soo Jin Kim, Kyung Yeon Kim. 2012. Porous Polyurethane Scaffold as a
Tracheal Prosthesis Material. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 55:1, 30. [CrossRef]
3. Eleftherios A. Makris, Pasha Hadidi, Kyriacos A. Athanasiou. 2011. The knee meniscus: Structure–function, pathophysiology,
current repair techniques, and prospects for regeneration. Biomaterials 32:30, 7411-7431. [CrossRef]
4. Natalie K. Galley, Jason P. Gleghorn, Scott Rodeo, Russell F. Warren, Suzanne A. Maher, Lawrence J. Bonassar. 2011.
Frictional Properties of the Meniscus Improve After Scaffold-augmented Repair of Partial Meniscectomy: A Pilot Study.
Clinical Orthopaedics and Related Research® . [CrossRef]
5. Lara C. Ionescu , Gregory C. Lee , Grant H. Garcia , Tiffany L. Zachry , Roshan P. Shah , Brian J. Sennett , Robert L.
Mauck . 2011. Maturation State-Dependent Alterations in Meniscus Integration: Implications for Scaffold Design and Tissue
Engineering. Tissue Engineering Part A 17:1-2, 193-204. [Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with
Links]
6. Jorn Op Den Buijs , Erik L. Ritman , Dan Dragomir-Daescu . 2010. Validation of a Fluid–Structure Interaction Model of
Solute Transport in Pores of Cyclically Deformed Tissue Scaffolds. Tissue Engineering Part C: Methods 16:5, 1145-1156.
[Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with Links]
7. T. CHANDYBiocompatibility of materials and its relevance to drug delivery and tissue engineering 301-325. [CrossRef]
8. Stephanie Grenier , Martin Sandig , Kibret Mequanint . 2009. Smooth Muscle #-Actin and Calponin Expression and
Extracellular Matrix Production of Human Coronary Artery Smooth Muscle Cells in 3D Scaffolds. Tissue Engineering Part
A 15:10, 3001-3011. [Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with Links]
9. Christopher Moraes, Yoan K. Kagoma, Bogdan M. Beca, Rachel L.M. Tonelli-Zasarsky, Yu Sun, Craig A. Simmons.
2009. Integrating polyurethane culture substrates into poly(dimethylsiloxane) microdevices. Biomaterials 30:28, 5241-5250.
[CrossRef]
10. Jorn Op Den Buijs , Lichun Lu , Steven M. Jorgensen , Dan Dragomir-Daescu , Michael J. Yaszemski , Erik L. Ritman . 2009.
Solute Transport in Cyclically Deformed Porous Tissue Scaffolds with Controlled Pore Cross-Sectional Geometries. Tissue
Engineering Part A 15:8, 1989-1999. [Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with Links]
11. Yuen Kee Tsui, Sylwester Gogolewski. 2009. Microporous biodegradable polyurethane membranes for tissue engineering.
Journal of Materials Science: Materials in Medicine 20:8, 1729-1741. [CrossRef]
12. B. G. Sengers, C. P. Please, M. Taylor, R. O. C. Oreffo. 2009. Experimental–Computational Evaluation of Human Bone
Marrow Stromal Cell Spreading on Trabecular Bone Structures. Annals of Biomedical Engineering 37:6, 1165-1176.
[CrossRef]
13. Jonathan D. Packer, Scott A. Rodeo. 2009. Meniscal Allograft Transplantation. Clinics in Sports Medicine 28:2, 259-283.
[CrossRef]
14. Masahiro Kino-Oka, Yasunori Takezawa, Masahito Taya. 2009. Quality control of cultured tissues requires tools for
quantitative analyses of heterogeneous features developed in manufacturing process. Cell and Tissue Banking 10:1, 63-74.
[CrossRef]
15. Ji Sun Park, Dae Gyun Woo, Han Na Yang, Hye Jin Lim, Kyong Mi Park, Kun Na, Keun-Hong Park. 2009. Chondrogenesis
of human mesenchymal stem cells encapsulated in a hydrogel construct: Neocartilage formation in animal models as both
mice and rabbits. Journal of Biomedical Materials Research Part A 9999A, NA-NA. [CrossRef]
16. R. G. J. C. Heijkants, R. V. van Calck, T. G. van Tienen, J. H. de Groot, A. J. Pennings, P. Buma, R. P. H. Veth, A. J. Schouten.
2008. Polyurethane scaffold formation via a combination of salt leaching and thermally induced phase separation. Journal of
Biomedical Materials Research Part A 87A:4, 921-932. [CrossRef]
17. Hong-Shik Choi, Hwal Suh, Ja-Hyun Lee, Si-Nae Park, Sang-Hyun Shin, Young-Ho Kim, Sung Min Chung, Hyun Kyung
Kim, Jae-Yol Lim, Han Su Kim. 2008. A polyethylene glycol grafted bi-layered polyurethane scaffold: preliminary study
of a new candidate prosthesis for repair of a partial tracheal defect. European Archives of Oto-Rhino-Laryngology 265:7,
809-816. [CrossRef]
18. Keun Hong Park, Kun Na. 2008. Effect of growth factors on chondrogenic differentiation of rabbit mesenchymal cells
embedded in injectable hydrogels. Journal of Bioscience and Bioengineering 106:1, 74-79. [CrossRef]
19. Masahiro Kino-oka, Yoshikatsu Maeda, Yasuaki Sato, Ali Baradar Khoshfetrat, Takeyuki Yamamoto, Katsura Sugawara,
Masahito Taya. 2008. Characterization of spatial growth and distribution of chondrocyte cells embedded in collagen gels
through a stereoscopic cell imaging system. Biotechnology and Bioengineering 99:5, 1230-1240. [CrossRef]
20. Kyusik Yun, Hyun Tae Moon. 2008. Inducing Chondrogenic Differentiation in Injectable Hydrogels Embedded with Rabbit
Chondrocytes and Growth Factor for Neocartilage Formation. Journal of Bioscience and Bioengineering 105:2, 122-126.
[CrossRef]
21. Greg Lemon, Sarah L. Waters, Felicity R.A.J. Rose, John R. King. 2007. Mathematical modelling of human mesenchymal
stem cell proliferation and differentiation inside artificial porous scaffolds. Journal of Theoretical Biology 249:3, 543-553.
[CrossRef]
22. G. Lemon, J. R. King. 2007. Travelling-wave behaviour in a multiphase model of a population of cells in an artificial scaffold.
Journal of Mathematical Biology 55:4, 449-480. [CrossRef]
23. Andre F. Steinert , Glyn D. Palmer , Ramille Capito , Jochen G. Hofstaetter , Carmencita Pilapil , Steven C. Ghivizzani ,
Myron Spector , Christopher H. Evans . 2007. Genetically Enhanced Engineering of Meniscus Tissue Using Ex Vivo Delivery
of Transforming Growth Factor-#1 Complementary Deoxyribonucleic Acid. Tissue Engineering 13:9, 2227-2237. [Abstract]
[Full Text PDF] [Full Text PDF with Links]
24. Joseph Jagur-Grodzinski. 2006. Polymers for tissue engineering, medical devices, and regenerative medicine. Concise general
review of recent studies. Polymers for Advanced Technologies 17:6, 395-418. [CrossRef]
25. Chapter 3 Basic Technologies Developed for Tissue Engineering 8, 235-421. [CrossRef]
